164
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Survival after percutaneous coronary intervention and coronary artery bypass grafting in a single centre

Pages 214-220 | Received 07 Jan 2007, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Per Mølstad. (2015) Survival difference between coronary bypass surgery and percutaneous coronary intervention. Scandinavian Cardiovascular Journal 49:4, pages 177-182.
Read now
Per Mølstad. (2012) Time dependent effect on mortality of drug-eluting stents versus bare metal stents. Scandinavian Cardiovascular Journal 46:4, pages 226-232.
Read now
Tor Melberg, Ottar Kjell Nygård, Karel Kier-Jan Kuiper & Jan Erik Nordrehaug. (2010) Competing risk analysis of events 10 years after revascularization. Scandinavian Cardiovascular Journal 44:5, pages 279-288.
Read now
Per Mølstad. (2009) Coronary heart disease in women: Less extensive disease and improved long-term survival compared to men. Scandinavian Cardiovascular Journal 43:1, pages 10-16.
Read now
Kristin V. T. Engebretsen, Kristin V. T. Engebretsen, Charlotte Friis, Leiv Sandvik & Theis Tønnessen. (2009) Survival after CABG – better than predicted by EuroSCORE and equal to the general population. Scandinavian Cardiovascular Journal 43:2, pages 123-128.
Read now

Articles from other publishers (3)

Hengyi Zhao & Daimin Zhang. (2020) Percutaneous Coronary Intervention Compared with Coronary Artery Bypass Graft Surgery for Patients With 3-vessel Disease: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant Systematic Review and Meta-analysis. Journal of Cardiovascular Pharmacology 76:5, pages 527-532.
Crossref
Torbj?rn Wisl?ff & Dan Atar. (2016) Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention. European Heart Journal - Quality of Care and Clinical Outcomes 2:1, pages 52-57.
Crossref
Torbjørn Wisløff, Dan Atar & Ivar Sønbø Kristiansen. (2013) Cost Effectiveness of Drug-Eluting Stents as Compared With Bare Metal Stents in Patients With Coronary Artery Disease. American Journal of Therapeutics 20:6, pages 596-601.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.